clinical data show significantly lower iud procedural pain and bleeding rates with aspivix's novel SUCTION-BASED CERVICAL Device
Retrieved on:
Wednesday, May 25, 2022
Department, Adolescence, Vacuum, Pain, Company, Michel Bernholc, Traction, Comparison, SA, Birth control, Fear, Norwest Venture Partners, Trauma, HUG, ZKB, European Society of Gynaecological Oncology, New Oakland Child-Adolescent and Family Center, Method, Birth, Advancing Women Artists Foundation, Designated terrorist organisations in Australia, Intrauterine device, Bleeding, IUD, Congress, Safety, Reproduction, Lausanne University Hospital, Geneva University Hospitals, CHUV, Atraumatic Restorative Treatment (ART), Framework Programmes for Research and Technological Development, Reproductive health, PMID, Woman
Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.
Key Points:
- Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.
- During IUD insertion, twice as many nulliparouswomenin the Carevix group were free of pain compared to those in the tenaculum group, and they reported an 88% lower rate of severe pain.
- Carevixis an innovative, soft-suction cervical device designed as a modern and gentler alternative to a cervical tenaculum when stabilization of the cervix is needed.
- A semi-circular, anatomical pad is applied onto the delicate tissue during gynecological procedures, reducing trauma associated with pain and bleeding.